期刊
BRITISH JOURNAL OF HAEMATOLOGY
卷 191, 期 4, 页码 568-572出版社
WILEY
DOI: 10.1111/bjh.17146
关键词
AML; therapeutic innovation; clinical trials
类别
资金
- Blood Cancer UK [19008] Funding Source: Medline
Outcomes in acute myeloid leukaemia have improved steadily over the last six decades thanks to advances in disease classification, risk stratification and the advent of new drug and transplant therapies. Over this period the UK has made a major contribution to this international effort, both through its delivery of large prospective randomised trials with integrated genomic and measurable residual disease assessments and its pioneering role in the development of allogeneic stem cell transplantation as a potent anti-leukaemic therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据